Literature DB >> 11726582

Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.

J X Wang1, M J Davies, R J Norman.   

Abstract

BACKGROUND: A high proportion of infertile patients have polycystic ovarian syndrome (PCOS) with a reportedly greater risk of spontaneous abortion. Because of the close link between PCOS and obesity and the independent association of obesity with poor pregnancy outcomes, it is important to distinguish the possible confounding effect of body mass index (BMI) or other variables from that of PCOS. This study aims to determine the effect of PCOS status on the risk of spontaneous abortion with adjustment for body mass and several other confounding factors in a large cohort of pregnant infertile women.
METHODS: The patients (n = 1018) were treated in a tertiary infertility centre. Their PCOS status was determined by standard criteria and their BMI had been taken less than 1 year before the pregnancy. Patients whose PCOS status or BMI measurements were not assessed were excluded. Student's t-test or chi2 test were used to test the difference between the PCOS and non-PCOS groups while a multivariate logistical regression model was used to assess the effect of PCOS, BMI and other confounding factors.
RESULTS: Overall, the incidence of PCOS was 37% in this cohort. The overall incidence of spontaneous abortion in the study population was 21%. Univariate analysis showed that women with PCOS had a significantly greater risk of spontaneous abortion compared with non-PCOS women (25 versus 18%, P < 0.01). However, using multivariate logistic regression analysis this effect was reduced to a non-significant level [odds ratio (OR) = 1.10, 95% confidence interval (CI) 0.85-1.36] after adjusting for obesity and patients/treatment combination factor, and to nil after adjusting for all confounding factors considered in this study (OR = 0.98, 95% CI 0.75-1.28).
CONCLUSION: The results of this study suggest that the higher risk of spontaneous abortion observed in women with PCOS is likely to be due to their high prevalence of obesity and the type of treatment they receive.

Entities:  

Mesh:

Year:  2001        PMID: 11726582     DOI: 10.1093/humrep/16.12.2606

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  32 in total

Review 1.  Management of infertility.

Authors:  D J Cahill; P G Wardle
Journal:  BMJ       Date:  2002-07-06

2.  Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles.

Authors:  Kerri L Marquard; Sahar M Stephens; Emily S Jungheim; Valerie S Ratts; Randall R Odem; Susan Lanzendorf; Kelle H Moley
Journal:  Fertil Steril       Date:  2010-11-11       Impact factor: 7.329

3.  Relationship between uterine natural killer cells and unexplained repeated miscarriage.

Authors:  Mohamed M Farghali; Abdel-Latif G El-Kholy; Khaled H Swidan; Ibrahim A Abdelazim; Ahmed R Rashed; Ezzat El-Sobky; Mostafa F Goma
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-11-02

4.  Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment.

Authors:  Hang Wun Raymond Li; Vivian Chi Yan Lee; Estella Yee Lan Lau; William Shu Biu Yeung; Pak Chung Ho; Ernest Hung Yu Ng
Journal:  J Assist Reprod Genet       Date:  2013-12-14       Impact factor: 3.412

5.  Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS.

Authors:  Deepika Garg; Richard Grazi; Geralyn M Lambert-Messerlian; Zaher Merhi
Journal:  J Assist Reprod Genet       Date:  2017-08-19       Impact factor: 3.412

6.  Association of polycystic ovary syndrome and a non-dipping blood pressure pattern in young women.

Authors:  Ayse Kargili; Feridun Karakurt; Benan Kasapoglu; Aysel Derbent; Cemile Koca; Yusuf Selcoki
Journal:  Clinics (Sao Paulo)       Date:  2010-05       Impact factor: 2.365

7.  The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial.

Authors:  Meike A Q Mutsaerts; Henk Groen; Nancy C W ter Bogt; Johanna H T Bolster; Jolande A Land; Wanda J E Bemelmans; Walter K H Kuchenbecker; Peter G A Hompes; Nick S Macklon; Ronald P Stolk; Fulco van der Veen; Jacques W M Maas; Nicole F Klijn; Eugenie M Kaaijk; Gerrit J E Oosterhuis; Peter X J M Bouckaert; Jaap M Schierbeek; Yvonne M van Kasteren; Annemiek W Nap; Frank J Broekmans; Egbert A Brinkhuis; Carolien A M Koks; Jan M Burggraaff; Adrienne S Blankhart; Denise A M Perquin; Marie H Gerards; Robert J A B Mulder; Ed T C M Gondrie; Ben W J Mol; Annemieke Hoek
Journal:  BMC Womens Health       Date:  2010-06-25       Impact factor: 2.809

8.  Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies.

Authors:  Hind A Beydoun; Laurel Stadtmauer; May A Beydoun; Helena Russell; Yueqin Zhao; Sergio Oehninger
Journal:  Reprod Biomed Online       Date:  2009-06       Impact factor: 3.828

9.  Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.

Authors:  D Fischer; C Reisenbüchler; S Rösner; J Haussmann; P Wimberger; M Goeckenjan
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-06       Impact factor: 2.915

10.  Mental health status assessment in polycystic ovarian syndrome infertility patients: A pilot study.

Authors:  Sai-Jiao Li; Dan-Ni Zhou; Wei Li; Jing Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.